Real-World Use of Letermovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients (IDWeek 2025) - Sep 3, 2025 - Abstract #P-2172; Pres time: Oct 22, 2025; 12:15 PM - 01:30 PM; Location: Virtual; No abstract available
Clinical • Real-world • Real-world evidence • Cytomegalovirus Infection • Infectious Disease
|
|
Athena Matsikas, PharmD; Srijana Jonchhe, PharmD, BCPS, BCTXP; Sapna A. Mehta, MD; fainareti Zervou, MD
|